Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.

AIDS (London, England)

Volumn 22 Suppl 1, Issue , 2008, Pages

  Aracena Genao, Belkis ^a   Navarro, Jesús Oaxaca ^a   Lamadrid Figueroa, Hector ^a   Forsythe, Steven ^a   Trejo Valdivia, Belem ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEXICO; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SURVIVAL; TIME;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HOSPITALS, PUBLIC; HUMANS; MALE; MEXICO; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME;

EID: 51549093833     PISSN: None     EISSN: 14735571     Source Type: Journal    
DOI: None     Document Type: Article

References (0)